Endo Health (ENDP +4.8%) settles two patent lawsuits with Watson Pharmaceuticals (WPI +1.8%) that will allow the latter to launch a generic version of Lidoderm, Endo's $1B+ pain-relieving patch, from September 2013, pending FDA approval. Watson will pay Endo a quarter of the gross profit as royalty.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Tue, 5:06PM)
at Zacks.com (Mon, 10:22AM)
at Zacks.com (Mon, 8:29AM)
at MarketWatch.com (Mon, 7:57AM)
at Zacks.com (Feb 27, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs